רשות המחקר

לוח קולות קוראים

יוני 2021

א'	ב'	ג'	ד'	ה'	ו'	ש'
30	31	1 BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01) National Institutes of Health (NIH) Sinergia Grants– interdisciplinary, collaborative and breakthrough Swiss national Science Foundation Rising Star Awards One Mind Institute Sinergia Grants– interdisciplinary, collaborative and breakthrough Swiss national Science Foundation 2021 Leukemia Research Grants When Everyone Survives Foundation (WES Foundation) Medical Research Grants: leukodystrophies and myelin repair ELA Foundation 2021 Dr. William E. Paul Distinguished Innovator Awards in Lupus Lupus Research Alliance Early-Career Research Grants Obesity Society Auditory Research grant Capita Foundation Sinergia Grants– interdisciplinary, collaborative and breakthrough Swiss national Science Foundation Research Related to Lennox Gastaut Syndrome LGS Foundation	2 Next-generation Data Infrastructure request for proposals Facebook Research Projects in Historical Humanities Gerda Henkel Foundation	3 2021 Vector-Borne Disease RFP AKC Canine Health Foundation	4 Research Grants Cure Parkinson’s Trust (CPT) Immune Development in Early Life (IDEaL) (U01) National Institutes of Health (NIH)	5 Co-infection and Cancer (R01) National Cancer Institute/NIH Research on Autism Spectrum Disorders (R01) National Institutes of Health (NIH)
		Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH
6	7	8 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01) National Cancer Institute/NIH Sustained Support for Informatics Technologies for Cancer Research and Management (U24) National Cancer Institute/NIH Advanced Development of Informatics Technologies for Cancer Research and Management (U24) National Cancer Institute/NIH Exploratory Grants in Cancer Epidemiology(R21) National Cancer Institute/NIH CDMRP Military Burn Research Program: Idea Development Award US Department of Defense CDMRP Military Burn Research Program: Clinical Translational Research Award US Department of Defense	9 Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21) National Cancer Institute/NIH	10 Research Interests of the Air Force Office of Scientific Research US Department of Defense Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01) National Institute of Mental Health/NIH Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21) National Institute of Mental Health/NIH Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21) National Cancer Institute/NIH Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01) National Cancer Institute/NIH קרן מנוף: קול קורא להגשת בקשות לפיתוח, יישום ושיפור של הבטיחות והגהות התעסוקתית במקומות העבודה National Insurance Institute	11 DARPA: DSO Office-wide BAA US Department of Defense	12 DARPA (TTO): Transforming the Battlespace US Department of Defense
		Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH
13	14 CDMRP Peer Reviewed Alzheimer's Research Program: Leveraging Approaches for Innovations in Care and Support Award US Department of Defense 2022 OCRA research grants Ovarian Cancer Research Fund Alliance CDMRP Peer Reviewed Alzheimer's Research Program: Convergence Science Research Award US Department of Defense CDMRP Epilepsy Research Program: Quality of Life Research Award US Department of Defense CDMRP Peer Reviewed Alzheimer's Research Program: Accelerating Diagnostics Research Award US Department of Defense MRP Peer Reviewed Alzheimer's Research Program: Innovations in Care and Support Award US Department of Defense CDMRP Epilepsy Research Program: Research Partnership Award US Department of Defense CDMRP Peer Reviewed Alzheimer's Research Program: Research Partnership Award US Department of Defense CDMRP Epilepsy Research Program: Idea Development Award US Department of Defense	15 The Cellular Scale Connectome in Aging and Alzheimer’s Disease (U01) National Institute on Aging/NIH Aging Effects on Osteoimmunology (R01) National Institute on Aging/NIH CDMRP Kidney Cancer Research Program: Idea Development Award US Department of Defense M-ERA.NET CALL 2021 Ministry of Science and Technology CDMRP Kidney Cancer Research Program: Translational Research Partnership Award US Department of Defense קול קורא למחקרים בנושא ראיה ממוחשבת ומידע חזותי - משרד הביטחון MAFAT Grants to assist visually impaired people Ulverscroft Foundation קול קורא להצעות מחקר בנושא אימפקט חברתי-כלכלי של תכניות התערבות חברתיות Edmond the Rothschild Foundation (IL) Osteology Research Grants Osteology Foundation Research Grants LAM Foundation	16 Research on Autism Spectrum Disorders (R03) National Institutes of Health (NIH) Research on Autism Spectrum Disorders (R21) National Institutes of Health (NIH) NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) National Institute of Child Health and Human Development/NIH ARI Research Grants Autism Research Institute Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) National Institute of Mental Health/NIH Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) National Institute of Mental Health/NIH DARPA (I2O): Computational Cultural Understanding (CCU) BAA US Department of Defense Co-infection and Cancer (R21) National Cancer Institute/NIH	17 Ethical, Legal and Social Implications (ELSI) of Human Genome Exploratory/Developmental Research (R21) National Institutes of Health (NIH) Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33) National Institute on Alcohol Abuse and Alcoholism/ NIH Ethical, Legal and Social Implications (ELSI) of Human Genome Exploratory/Developmental Research (R03) National Institutes of Health (NIH) Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34) National Institute on Alcohol Abuse and Alcoholism/ NIH Ethical, Legal and Social Implications (ELSI) of Human Genome Research (R01) National Institutes of Health (NIH) New Approaches to Identify Neurogenesis and Study its Dynamics in Brain Aging and AD/ADRD (R01( National Institute on Aging/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33) National Institute of Neurological Disorders and Stroke/NIH Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33) National Institutes of Health (NIH) Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33) National Institute of Neurological Disorders and Stroke/NIH	18 Research Grants Program National Rosacea Society	19 Fertility Status as a Marker for Overall Health (R01) National Institutes of Health (NIH) Fertility Status as a Marker for Overall Health (R21) National Institutes of Health (NIH)
	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH
20 Facioscapulohumeral Muscular Dystrophy Research Grants FSH Society	21 NCI Clinical and Translational Exploratory/Developmental Studies (R21) National Cancer Institute/NIH NCI Clinical and Translational Exploratory/Developmental Studies (R21) National Cancer Institute/NIH Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3) National Institute of Mental Health/NIH	22 HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34) National Institutes of Health (NIH) Computer-Aided Design and Test (CADT) Call for Research Semiconductor Research Corporation CDMRP Kidney Cancer Research Program: Concept Award US Department of Defense HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19) National Institutes of Health (NIH) The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01) National Institutes of Health (NIH)	23 The Minerva Research Initiative US Department of Defense	24 NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03) National Cancer Institute/NIH CDMRP Breast Cancer Research Program Transformative Breast Cancer Consortium Award US Department of Defense Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33) National Institute on Drug Abuse/NIH CDMRP Breast Cancer Research Program Innovator Award US Department of Defense CDMRP Ovarian Cancer Omics Consortium Development Award US Department of Defense CDMRP Ovarian Cancer Omics Consortium Award US Department of Defense CDMRP Breast Cancer Breakthrough Award Level 4 US Department of Defense CDMRP Breast Cancer Breakthrough Award Level 3 US Department of Defense	25 Packaging (PKG) Call for Research Semiconductor Research Corporation	26
Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH
27	28	29 AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants American Association for Cancer Research CDMRP Melanoma Research Program: Melanoma Academy Scholar Award US Department of Defense ERA-NET TRANSCAN-3: Next generation cancer immunotherapy: targeting the tumour microenvironment Ministry of Health AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants American Association for Cancer Research CDMRP Melanoma Research Program: Idea Award US Department of Defense	30 קול קורא למחקר ברפואה צבאית 2022 Israel Defense Forces / Medical Corps CDMRP Multiple Sclerosis Research Program: Investigator-Initiated Award US Department of Defense DWRF Research Grants Diabetes Research and Wellness Foundation IBM Research Report Stipends IBM Center for The Business of Government Environmental Projects and Research Grants 2023 Prince Albert II of Monaco Foundation AA and MDSIF Grant Opportunities Aplastic Anemia & MDS International Foundation ACT for IFOPA Research Grants International Fibrodysplasia Ossificans Progressiva Association Dharam Ablashi Research Fund – Pilot Grant Program HHV-6 Foundation OPRA Research Grants Association for Advancement of Research on Open Problems In Nuclear and Particle Physics (OPRA) IOIBD Grants International Organization For the Study of Inflammatory Bowel Disease (IOIBD) ADVANCED RESEARCH GRANTS IN ALS Radala Foundation Navy Research Lab (NRL): Long Range BAA for Basic and Applied Research US Department of Defense 2021 Statistics for Improving Insights, Models, and Decisions request for proposals Facebook CDMRP Multiple Sclerosis Research Program: Exploration-Hypothesis Development Award US Department of Defense 2021-2022 Research Grants- Parkinson's and Exercise Davis Phinney Foundation Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	1	2	3
		Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH	Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33) National Institute of Allergy and Infectious Diseases/NIH